ClinicalTrials.Veeva

Menu

Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1

A

Antalya Training and Research Hospital

Status

Active, not recruiting

Conditions

Myotonic Dystrophy Type 1
Falls

Study type

Observational

Funder types

Other

Identifiers

NCT07493525
2025-217

Details and patient eligibility

About

This cross-sectional observational study aims to determine the frequency of falls in patients with myotonic dystrophy type 1 and to identify factors affecting dynamic balance. The study will also evaluate fear of falling, selected lower extremity muscle strength, and the relationship between muscle strength and fall frequency. The findings may contribute to a better understanding of fall risk and balance impairment in patients with myotonic dystrophy type 1.

Full description

Myotonic dystrophy type 1 is a multisystem neuromuscular disorder characterized by myotonia, progressive muscle weakness, and functional limitations. Distal muscle weakness, impaired postural control, and gait dysfunction may increase the risk of falls and negatively affect daily activities and quality of life. Although falls and balance impairment are clinically important in patients with myotonic dystrophy type 1, data on fall frequency and factors affecting dynamic balance remain limited.

This single-center, hospital-based, cross-sectional observational study will be conducted in patients with myotonic dystrophy type 1 who are followed at the Neuromuscular Diseases Center of Antalya Training and Research Hospital. The study aims to determine fall frequency and to investigate factors affecting dynamic balance. Fear of falling, lower extremity muscle strength, and dynamic balance performance will be assessed, and the relationship between muscle strength and fall frequency will be examined. The results are expected to improve the understanding of fall-related impairments in myotonic dystrophy type 1 and support more comprehensive clinical assessment and rehabilitation planning.

Enrollment

41 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged between 18 and 60 years old
  • Diagnosis of myotonic dystrophy type 1
  • Ability to understand and follow study instructions
  • Ability to ambulate, with or without an assistive device, sufficiently to perform the study assessments
  • Willingness to participate and provide written informed consent

Exclusion criteria

  • Severe cognitive impairment interfering with understanding or completion of the study assessments
  • Severe visual impairment interfering with balance and mobility testing
  • Severe sensory impairment, including markedly impaired vibration sensation, that may affect balance assessment
  • Any additional neurological, musculoskeletal, vestibular, or other medical condition that could substantially affect gait, balance, or fall risk independently of myotonic dystrophy type 1
  • Acute medical condition or unstable clinical status at the time of assessment
  • Inability to complete the study evaluations

Trial design

41 participants in 1 patient group

Myotonic Dystrophy Type 1 Group
Description:
Patients with myotonic dystrophy type 1 who are evaluated for fall frequency, dynamic balance, fear of falling, and lower extremity muscle strength.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems